Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 49-60 of 2,301
Drug study icon
Enrolling By InvitationNCT06922110

An Study of Azetukalner in Major Depressive Disorder

This study is enrolling by invitation in the United States. It is testing azetukalner for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.Over 18 Years
Countries
United States
Sponsor
Xenon Pharmaceuticals Inc.
Condition
Depression
Other study type icon
Enrolling By InvitationNCT05910957

Multi-Omic, Clinomic and Digitomic Attributes of Major Depression for Integrative Analytics

This observational study is following people with depression or Unipolar, Non-psychotic depression to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Why is this study shown?

This study is directly about Depression.

Depression, SchizophreniaOtherFrom 20 Years to 62 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression, Schizophrenia
Drug study icon
Enrolling By InvitationNCT06580041

Precision Care for Major Depressive Disorder

This study is looking at whether Pramipexole can help people with depression or major depression. Participants take part in Pramipexole and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
Behavioral study icon
Enrolling By InvitationNCT04509102

Psychostimulant Augmentation of Repetitive TMS for Major Depressive Disorder

This study is looking at enroll a total of 30 Subjects for people with depression. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, Los Angeles
Condition
Depression
Drug study icon
RecruitingNCT06668571

Intravenous Ketamine for Treatment-Resistant Depression

This study is looking at care and outcomes for people with depression, Treatment-Resistant or Treatment Resistant Depression. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression
Behavioral study icon
RecruitingNCT07512284

Mindfulness Engaged Neurostimulation for Depression (MEND II)

This study exists to see whether a therapy or guided support program can play a useful role in care. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Diego
Condition
Depression
Device study icon
Not Yet RecruitingNCT07227103

Randomized, Double-Blind Controlled Comparison of NRX-101 for treatment-resistant depression

This study is not yet recruiting in the United States. It is testing Randomized, Double-Blind Controlled Comparison of NRX-101 for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 80 Years
Countries
United States
Sponsor
NeuroRx, Inc.
Condition
Depression
Drug study icon
Not Yet RecruitingNCT07247006

Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression

This study is looking at further understand if there is a connection between this new change of mind and changes in brain activity for people with Treatment Resistant Depression or Chronic Pain. Participants receive a study treatment and complete follow-up visits and assessments.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
University of Rochester
Condition
Depression
Behavioral study icon
RecruitingNCT07563868

Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression

This study exists to understand how a therapy or guided support program holds up over time after the earliest research stage. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
Device study icon
RecruitingNCT05773755

DBS for TRD With the Medtronic Percept PC

This observational study is following people with depression or Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 25 Years to 70 Years
Countries
United States
Sponsor
Helen Mayberg, MD
Condition
Depression
Drug study icon
RecruitingNCT07369102

Esketamine With or Without Integration Therapy for Treatment-Resistant Depression

This study is looking at explore the effects of esketamine (Spravato®), an FDA-approved nasal spray, on adults diagnosed with treatment-resistant depression (TRD). Participants receive a study treatment and complete follow-up visits and assessments.

Broader result
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 21 Years to 65 Years
Countries
United States
Sponsor
University of Puerto Rico
Condition
Depression
Device study icon
RecruitingNCT06982820

Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia

This study is looking at whether Prism Training can help people with major depression. Participants take part in Prism Training and complete follow-up assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 22 Years to 75 Years
Countries
United States, Israel
Sponsor
GrayMatters Health Ltd.
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.